Kaplan–Meier plots showed a significant survival difference between the high- and low-TRH groups in the intermediate group (p = 0.0408) and adverse group (p = 0.284), respectively, in the TCGA AML cohort (Figure 6c). This evidence concerns the gene TRH and acute myeloid leukemia.